Analyst initiated coverage on Heartflow with a new price target
$HTFL
Medical/Dental Instruments
Health Care
Analyst initiated coverage of Heartflow with a rating of Overweight and set a new price target of $36.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/2/2025 | $36.00 | Overweight | Analyst |
| 9/2/2025 | $38.00 | Overweight | Piper Sandler |
| 9/2/2025 | $35.00 | Buy | Stifel |
| 9/2/2025 | $35.00 | Buy | Canaccord Genuity |
| 9/2/2025 | $35.00 | Equal-Weight | Morgan Stanley |
8-K - Heartflow, Inc. (0001464521) (Filer)
S-8 - Heartflow, Inc. (0001464521) (Filer)
S-8 - Heartflow, Inc. (0001464521) (Filer)
MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. The fireside chat will take place on Wednesday, September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET. A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com. About Heartflow, Inc.Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosab
MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its common stock at a public offering price of $19 per share, which includes 2,500,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were offered by Heartflow. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Heartflow, were approximately $364.2
4 - Heartflow, Inc. (0001464521) (Issuer)
3 - Heartflow, Inc. (0001464521) (Issuer)
4 - Heartflow, Inc. (0001464521) (Issuer)
Analyst initiated coverage of Heartflow with a rating of Overweight and set a new price target of $36.00
Piper Sandler initiated coverage of Heartflow with a rating of Overweight and set a new price target of $38.00
Stifel initiated coverage of Heartflow with a rating of Buy and set a new price target of $35.00